Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Retained Earnings: 2010-2025

Historic Retained Earnings for Catalyst Pharmaceuticals (CPRX) over the last 13 years, with Sep 2025 value amounting to $446.8 million.

  • Catalyst Pharmaceuticals' Retained Earnings rose 94.91% to $446.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $446.8 million, marking a year-over-year increase of 94.91%. This contributed to the annual value of $285.2 million for FY2024, which is 135.14% up from last year.
  • Catalyst Pharmaceuticals' Retained Earnings amounted to $446.8 million in Q3 2025, which was up 13.40% from $394.0 million recorded in Q2 2025.
  • In the past 5 years, Catalyst Pharmaceuticals' Retained Earnings ranged from a high of $446.8 million in Q3 2025 and a low of -$46.3 million during Q1 2021.
  • For the 3-year period, Catalyst Pharmaceuticals' Retained Earnings averaged around $221.0 million, with its median value being $185.3 million (2024).
  • Data for Catalyst Pharmaceuticals' Retained Earnings shows a peak YoY surged of 7,032.81% (in 2023) over the last 5 years.
  • Catalyst Pharmaceuticals' Retained Earnings (Quarterly) stood at -$26.3 million in 2021, then surged by 289.52% to $49.9 million in 2022, then skyrocketed by 143.22% to $121.3 million in 2023, then skyrocketed by 135.14% to $285.2 million in 2024, then spiked by 94.91% to $446.8 million in 2025.
  • Its Retained Earnings was $446.8 million in Q3 2025, compared to $394.0 million in Q2 2025 and $341.9 million in Q1 2025.